Alpha-blockade during congenital heart surgery admissions: analysis from national database

Abstract Introduction: The effects of alpha-blockade on haemodynamics during and following congenital heart surgery are well documented, but data on patient outcomes, mortality, and hospital charges are limited. The purpose of this study was to characterise the use of alpha-blockade during congenital heart surgery admissions and to determine its association with common clinical outcomes. Materials and Methods: A cross-sectional study was conducted using the Pediatric Health Information System database. De-identified data for patients under 18 years of age with a cardiac diagnosis who underwent congenital heart surgery were obtained from 2004 to 2015. Patients were subdivided on the basis of receiving alpha-blockade with either phenoxybenzamine or phentolamine during admission or not. Continuous and categorical variables were analysed using Mann−Whitney U-tests and Fisher exact tests, respectively. Characteristics between subgroups were compared using univariate analysis. Regression analyses were conducted to determine the impact of alpha-blockade on ICU length of stay, hospital length of stay, billed charges, and mortality. Results: Of the 81,313 admissions, 4309 (5.3%) utilised alpha-blockade. Phentolamine was utilised in 4290 admissions. In univariate analysis, ICU length of stay, total length of stay, inpatient mortality, and billed charges were all significantly higher in the alpha-blockade admissions. However, regression analyses demonstrated that other factors were behind these increased. Alpha-blockade was significantly, independently associated with a 1.5 days reduction in ICU length of stay (p < 0.01) and a 3.5 days reduction in total length of stay (p < 0.01). Alpha-blockade was significantly, independently associated with a reduction in mortality (odds ratio 0.8, 95% confidence interval 0.7−0.9). Alpha-blockade was not independently associated with any significant change in billed charges. Conclusions: Alpha-blockade is used in a subset of paediatric cardiac surgeries and is independently associated with significant reductions in ICU length of stay, hospital length of stay, and mortality without significantly altering billed charges.

[1]  U. Kiran,et al.  Alpha blockers: A relook at phenoxybenzamine , 2017 .

[2]  K. Pankaj,et al.  Role of phenoxybenzamine in perioperative clinical practice. , 2015, Annals of cardiac anaesthesia.

[3]  O. Morozova,et al.  Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia , 2015, BMC Medical Research Methodology.

[4]  R. Neirotti,et al.  Neonatal Heart Surgery: Evaluation of Risk Factors , 2011 .

[5]  A. Saxena,et al.  Primary arterial switch operation in children presenting late with d-transposition of great arteries and intact ventricular septum. When is it too late for a primary arterial switch operation? , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  N. Fernandez,et al.  [Neonatal cardiac surgery: assessment and comparison of surgical results using the RACHS-1 risk adjustment method]. , 2009, Archivos argentinos de pediatria.

[7]  E. Mossad,et al.  The hemodynamic effects of phenoxybenzamine in neonates, infants, and children. , 2008, Journal of clinical anesthesia.

[8]  U. Kiran,et al.  Combination of low-dose phenoxybenzamine and sodium nitroprusside in children undergoing cardiac surgery. , 2006, Journal of cardiothoracic and vascular anesthesia.

[9]  U. Kiran,et al.  Combination of phenoxybenzamine and nitroglycerin: effective control of pulmonary artery pressures in children undergoing cardiac surgery. , 2005, Journal of cardiothoracic and vascular anesthesia.

[10]  M. Zestos,et al.  Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. , 2005, Journal of cardiothoracic and vascular anesthesia.

[11]  W. Williams,et al.  Prevention of Early Sudden Circulatory Collapse After the Norwood Operation , 2004, Circulation.

[12]  S. Berger,et al.  Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the Norwood procedure. , 2004, The Journal of thoracic and cardiovascular surgery.

[13]  S. Berger,et al.  Improved Survival of Patients Undergoing Palliation of Hypoplastic Left Heart Syndrome: Lessons Learned From 115 Consecutive Patients , 2002, Circulation.

[14]  I. Konstantinov,et al.  Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure. , 2002, The Journal of thoracic and cardiovascular surgery.

[15]  K. Karaoğlu,et al.  Effects of phentolamine on tissue perfusion in pediatric cardiac surgery. , 1999, Journal of cardiothoracic and vascular anesthesia.

[16]  J. Ruskin,et al.  Primary pulmonary hypertension treated with oral phentolamine. , 1979, Annals of internal medicine.

[17]  M. Yamaguchi,et al.  The effect of phenoxybenzamine on the pulmonary vascular bed in surgically corrected ventricular septal defect associated with pulmonary hypertension. , 1979, Japanese heart journal.

[18]  H. Matsumoto,et al.  The application of phenoxybenzamine in open heart surgery using cardiopulmonary bypass. , 1976, The Journal of cardiovascular surgery.

[19]  J. Straker,et al.  The effect of levarterenol and phentolamine on the hypertensive pulmonary vasculature. , 1973, The Annals of thoracic surgery.

[20]  G. Sutherland,et al.  The Circulatory Effects of Intravenous Phentolamine in Man , 1965, Circulation.

[21]  C. E. Jones,et al.  Cardiac and coronary effects of prazosin and phenoxybenzamine during coronary hypotension. , 1986, The Journal of pharmacology and experimental therapeutics.